Scientists have said a new schizophrenia drug "has the potential to change the lives of millions of people". The US Food and Drug Administration (FDA) has approved the new drug Cobenfy, which is owned ...
Fintel reports that on September 18, 2024, Leerink Partners initiated coverage of ICON Public Limited ( NasdaqGS:ICLR) with a Outperform recommendation.